HPV vaccines for prevention of cervical pre-cancer in adolescent girls and women
The evidence presented in this Cochrane meta-analysis shows the HPV vaccination confers significant benefit in preventing cervical pre-cancer. NNT of 60 for preventing one cervical pre-cancer (women 15 to 25 years old with or without HPV infection). The effect is higher for lesions associated with H...
Main Authors: | Jia Jian Li, Jessica Stetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Escola Bahiana de Medicina e Saúde Pública
2019-10-01
|
Series: | Journal of Evidence-Based Healthcare |
Subjects: | |
Online Access: | https://www5.bahiana.edu.br/index.php/evidence/article/view/2510 |
Similar Items
-
HPV Vaccination for Cervical Cancer Prevention in Switzerland
by: Emilien Jeannot, et al.
Published: (2023-04-01) -
Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians
by: Ana Carolina da Silva Santos, et al.
Published: (2020-03-01) -
Comment on “Will HPV vaccination prevent cervical cancer”
by: Shaokai Zhang, et al.
Published: (2020-04-01) -
Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical Epithelial Lesions: Survey and Insights from a German Study
by: Mahmoud Abbas, et al.
Published: (2023-07-01) -
Knowledge, Attitudes and Behaviors of Medical School Students about HPV, HPV Vaccine and Cervical Cancer: A Survey Study in a Medical School
by: Ahmet Mert Ulucan, et al.
Published: (2022-12-01)